The SAPALDIA Cohort - More than 25 Years of Research for Better Health
From Exposome to Phenome
The SAPALDIA cohort investigates since 1991 the effects of life style and environment on the chronic diseases and aging in adults of the Swiss general population. The SAPALDIA study participants have been recruited from 8 areas of Switzerland which differ by culture, language, geography, micro-climate, socio-demography and environmental exposures. The aim of baseline examination (Study on Air Pollution And Lung Disease In Adults, SAPALDIA) in 1991 was to identify and quantify the long-term effect of air pollution on the respiratory health of the adult general population in Switzerland. Ten years later, 83% of the 9561 original study participants agreed to a follow-up examination in 2002 (SAPALDIA2, n=8047).
At this follow-up the disease focus was expanded to also include cardiovascular and metabolic health. To investigate causal biologic mechanisms a systematic prospective collection of population-based blood samples was started and the SAPALDIA biobank was established. There has been a third and fourth follow-up inviting the same participants for additional data collection including detailed questionnaires, clinical examination and health measures (SAPALDIA3 in 2010, SAPALDIA4 in 2017 and SAPLDIA5 currently ongoing). SAPALDIA is one of the very few population-based adult longitudinal cohort studies in Europe examining the exposome cardio-respiratory disease, multi-morbidity, and also healthy aging. SAPALDIA can address environmental and health policy questions to guide evidence–based decisions in Switzerland and to improve quality of life of the aging Swiss population.
SAPALDIA Centres & Local Centre Directors
SAPALDIA is currently supported by
Since 1991 the SAPALDIA project has been supported by the Federal Office for the Environment, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Valais, and Zürich, the Swiss Lung League, the canton's Lung League of Basel Stadt/ Basel Landschaft, Geneva, Ticino, Valais, Graubünden and Zurich, Stiftung ehemals Bündner Heilstätten, SUVA, Freiwillige Akademische Gesellschaft, UBS Wealth Foundation, Talecris Biotherapeutics GmbH, Abbott Diagnostics, Klinik Barmelweid, Hirslanden Klinik Aarau, European Commission 018996 (GABRIEL), Wellcome Trust WT 084703MA, Exposomics EC FP7 grant(Grant agreement No: 308610).